Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alvaro Alonso

Showing results (361-370 of 702) with videos related to

Pageof 71
Sort By:
BMC Cardiovascular Disorders|September 7, 2017
Comparative effectiveness of rivaroxaban versus warfarin or dabigatran for the treatment of patients with non-valvular atrial fibrillationFaye L Norby, Lindsay G S Bengtson, Pamela L Lutsey, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 22, 2017
Midlife cardiovascular health and 20-year cognitive decline: Atherosclerosis Risk in Communities Study resultsHector M González, Wassim Tarraf, Kimystian Harrison, et al.
Annals of Noninvasive Electrocardiology : the Official Journal of the International Society for Holter and Noninvasive Electrocardiology, Inc|July 3, 2018
Sleep-disordered breathing and electrocardiographic QRS-T angle: The MESA studyYounghoon Kwon, Jeffrey R Misialek, Daniel Duprez, et al.
The American Journal of Cardiology|December 12, 2018
Relation of the CHA<sub>2</sub>DS<sub>2</sub>-VASc Score to Risk of Thrombotic and Embolic Stroke in Community-Dwelling Individuals Without Atrial Fibrillation (From The Atherosclerosis Risk in Communities [ARIC] Study)Ryan J Koene, M Chadi Alraies, Faye L Norby, et al.
Journal of Clinical Gastroenterology|January 20, 2021
Proton Pump Inhibitor Use, Hypomagnesemia and Risk of Cardiovascular Diseases: The Atherosclerosis Risk in Communities (ARIC) StudyMary R Rooney, Elizabeth J Bell, Alvaro Alonso, et al.
Research and Practice in Thrombosis and Haemostasis|March 27, 2023
Autoimmune disease and risk of postpartum venous thromboembolismRob F Walker, Neil A Zakai, Susan M Mason, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|March 7, 2023
Prevalence of suspected dementia in a sample of adults living in Kinshasa-Democratic Republic of the CongoJean Ikanga, Anny Reyes, Didine Kaba, et al.
Heart (British Cardiac Society)|November 21, 2014
Obesity related risk of sudden cardiac death in the atherosclerosis risk in communities studySelcuk Adabag, Rachel R Huxley, Faye L Lopez, et al.
Journal of the American Heart Association|September 20, 2014
Circulating fibroblast growth factor-23 and the incidence of atrial fibrillation: the Atherosclerosis Risk in Communities studyAlvaro Alonso, Jeffrey R Misialek, John H Eckfeldt, et al.
American Heart Journal|September 1, 2014
Parathyroid hormone concentration and risk of cardiovascular diseases: the Atherosclerosis Risk in Communities (ARIC) studyAaron R Folsom, Alvaro Alonso, Jeffrey R Misialek, et al.
Pageof 71

Showing results (361-370 of 702) with videos related to

Sort By:
Pageof 71
BMC Cardiovascular Disorders|September 7, 2017
Comparative effectiveness of rivaroxaban versus warfarin or dabigatran for the treatment of patients with non-valvular atrial fibrillationFaye L Norby, Lindsay G S Bengtson, Pamela L Lutsey, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 22, 2017
Midlife cardiovascular health and 20-year cognitive decline: Atherosclerosis Risk in Communities Study resultsHector M González, Wassim Tarraf, Kimystian Harrison, et al.
Annals of Noninvasive Electrocardiology : the Official Journal of the International Society for Holter and Noninvasive Electrocardiology, Inc|July 3, 2018
Sleep-disordered breathing and electrocardiographic QRS-T angle: The MESA studyYounghoon Kwon, Jeffrey R Misialek, Daniel Duprez, et al.
The American Journal of Cardiology|December 12, 2018
Relation of the CHA<sub>2</sub>DS<sub>2</sub>-VASc Score to Risk of Thrombotic and Embolic Stroke in Community-Dwelling Individuals Without Atrial Fibrillation (From The Atherosclerosis Risk in Communities [ARIC] Study)Ryan J Koene, M Chadi Alraies, Faye L Norby, et al.
Journal of Clinical Gastroenterology|January 20, 2021
Proton Pump Inhibitor Use, Hypomagnesemia and Risk of Cardiovascular Diseases: The Atherosclerosis Risk in Communities (ARIC) StudyMary R Rooney, Elizabeth J Bell, Alvaro Alonso, et al.
Research and Practice in Thrombosis and Haemostasis|March 27, 2023
Autoimmune disease and risk of postpartum venous thromboembolismRob F Walker, Neil A Zakai, Susan M Mason, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|March 7, 2023
Prevalence of suspected dementia in a sample of adults living in Kinshasa-Democratic Republic of the CongoJean Ikanga, Anny Reyes, Didine Kaba, et al.
Heart (British Cardiac Society)|November 21, 2014
Obesity related risk of sudden cardiac death in the atherosclerosis risk in communities studySelcuk Adabag, Rachel R Huxley, Faye L Lopez, et al.
Journal of the American Heart Association|September 20, 2014
Circulating fibroblast growth factor-23 and the incidence of atrial fibrillation: the Atherosclerosis Risk in Communities studyAlvaro Alonso, Jeffrey R Misialek, John H Eckfeldt, et al.
American Heart Journal|September 1, 2014
Parathyroid hormone concentration and risk of cardiovascular diseases: the Atherosclerosis Risk in Communities (ARIC) studyAaron R Folsom, Alvaro Alonso, Jeffrey R Misialek, et al.
Pageof 71